4DMedical Ltd (AU:4DX) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd, a respiratory imaging technology firm, has seen a significant 422% increase in operating revenue to $3.8 million for FY2024, driven primarily by Software-as-a-Service sales. The company has strategically acquired AI medical imaging company Imbio, which is expected to become cash flow positive within the year. Additionally, new FDA approvals, CMS reimbursements, and commercial agreements, including a Teaming Agreement with Philips for U.S. VA commercialization, position 4DMedical for further growth.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.